Amplification and overexpression of the L-MYC proto-oncogene in ovarian carcinomas

American Journal of Pathology

Volumn 162, Issue 5, 2003, Pages 1603-1610

  Wu, Rong ^a   Lin, Lin ^a   Beer, David G ^a   Ellenson, Lora H ^b   Lamb, Barbara J ^a   Rouillard, Jean Marie ^a   Kuick, Rork ^a   Hanash, Samir ^a   Schwartz, Donald R ^a   Fearon, Eric R ^a   Cho, Kathleen R ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c 4301 MSRBIII ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FEMALE; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; ONCOGENE C MYB; ONCOGENE C MYC; ONCOGENE L MYC; OVARY CARCINOMA; PRIORITY JOURNAL; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0242669283     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64294-0     Document Type: Article

References (59)

1. Schwab M: Amplification of oncogenes in human cancer cells. Bioessays 1998, 20:473-479
2. Heerdt BG, Molinas S, Deitch D, Augenlicht LH: Aggressive subtypes of human colorectal tumors frequently exhibit amplification of the c-MYC gene. Oncogene 1991, 6:125-129
3. Jenkins RB, Qian, J, Lieber MM, Bostwick DG: Detection of c-MYC oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Cancer Res 1997, 57:524-531
4. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove JA, Ullrich A: Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989, 244:707-712
5. Bonilla M, Ramirez M, Lopez-Cueto J, Gariglio P: In vivo amplification and rearrangement of c-MYC oncogene in human breast tumors. J Natl Cancer Inst 1988, 80:665-671
6. Little CD, Nau MM, Carney DN, Gazdar AF, Minna JD: Amplification and expression of the c-MYC oncogene in human lung cancer cell lines. Nature 1983, 306:194-196
7. Wong AJ, Ruppert JM, Eggleston J, Hamilton SR, Baylin SB, Vogelstein B: Gene amplification of c-MYC and N-MYC in small cell carcinoma of the lung. Science 1986, 233:461-464
8. Sharma A, Pratap M, Sawhney VM, Khan IU, Bhambhani S, Mitra AB: Frequent amplification of C-erbB2 (HER-2/Neu) oncogene in cervical carcinoma as detected by non-fluorescence in situ hybridization technique on paraffin sections. Oncology 1999, 56:83-87
9. Fukushi Y, Sato S, Yokoyama Y, Kudo K, Maruyama H, Saito Y: Detection of numerical aberration in chromosome 17 and c-erbB2 gene amplification in epithelial ovarian cancer using recently established dual color FISH. Eur J Gynaecol Oncol 2001, 22:23-25
10. Vos CB, Ter Haar NT, Peterse JL, Cornelisse CJ, van de Vijver MJ: Cyclin D1 gene amplification and overexpression are present in ductal carcinoma in situ of the breast. J Pathol 1999, 187:279-284
11. Lin L, Prescott MS, Zhu Z, Singh P, Chun SY, Kuick RD, Hanash SM, Orringer MB, Glover TW, Beer DG: Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals cyclin E as the best candidate gene for this amplicon. Cancer Res 2000, 60:7021-7027
12. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM: Amplification of N-MYC in untreated human neuroblastomas correlates with advanced disease stage. Science 1984, 224:1121-1124
13. Seshadri R, Matthews C, Dobrovic A, Horsfall DJ: The significance of oncogene amplification in primary breast cancer. Int J Cancer 1989, 43:270-272
14. Mizutani T, Onda M, Tokunaga A, Yamanaka N, Sugisaki Y: Relationship of C-erbB-2 protein expression and gene amplification to invasion and metastasis in human gastric cancer. Cancer 1993, 72: 2083-2088
15. Jernal A, Thomas A, Murray T, Thun M: Cancer statistics, 2002. CA Cancer J Clin 2002, 52:23-47
16. Feeley KM, Wells M: Precursor lesions of ovarian epithelial malignancy. Histopathology 2001, 38:87-95
17. Aunoble B, Sanches R, Didier E, Bignon YJ: Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer. Int J Oncol 2000, 16:567-576
18. Lynch HT, Casey MJ, Lynch J, White TE, Godwin AK: Genetics and ovarian carcinoma. Semin Oncol 1998, 25:265-280
19. Leary JA, Edwards BG, Houghton CR, Kefford RF, Friedlander ML: Amplification of HER-2/neu oncogene in human ovarian cancer. Int J Gynecol Cancer 1992, 2:291-294
20. Ross JS, Yang F, Kallakury BV, Sheehan CE, Ambros RA, Muraca PJ: HER-2/neu oncogene amplification by fluorescence in situ hybridization in epithelial tumors of the ovary. Am J Clin Pathol 1999, 111:311-316
21. Afify AM, Werness BA, Mark HF: HER-2/neu oncogene amplification in stage I and stage III ovarian papillary serous carcinoma. Exp Mol Pathol 1999, 66:163-169
22. Baker VV, Borst MP, Dixon D, Hatch KD, Shingleton HM, Miller DE:C-MYC amplification in ovarian cancer. Gynecol Oncol 1990, 38: 340-342
23. Schreiber G, Dubeau L: C-MYC proto-oncogene amplification detected by polymerase chain reaction in archival human ovarian carcinomas. Am J Pathol 1990, 137:653-658
24. Wang ZR, Liu W, Smith ST, Parrish RS, Young SR: c-MYC and chromosome 8 centromere studies of ovarian cancer by interphase FISH. Exp Mol Pathol 1999, 66:140-148
25. Berns EM, Kliin JG, Henzen-Logmans SC, Rodenburg CJ, van der Burg ME, Foekens JA: Receptors for hormones and growth factors and (onco)-gene amplification in human ovarian cancer. Int J Cancer 1992, 52:218-224
26. Asakawa J, Kuick R, Neel JV, Kodaira M, Satoh C, Hanash SM: Genetic variation detected by quantitative analysis of end-labeled genomic DNA fragments. Proc Natl Acad Sci USA 1994, 91: 9052-9056
27. Hatada I, Hayashizaki Y, Hirotsune S, Komatsubara H, Mukai T: A genomic scanning method for higher organisms using restriction sites as landmarks. Proc Natl Acad Sci USA 1991, 88:9523-9527
28. Hirotsune S, Hatada I, Komatsubara H, Nagai H, Kuma K, Kobayakawa K, Kawara T, Nakagawara A, Fujii K, Mukai T, Hiyshizaki Y: New approach for detection of amplification in cancer DNA using restriction landmark genomic scanning. Cancer Res 1992, 52:3642-3647
29. Wimmer K, Kuick R, Thoraval D, Hanash SM: Two-dimensional separations of the genome and proteome of neuroblastoma cells. Electrophoresis 1996, 17:1741-1751
30. Wimmer K, Thoraval D, Asakawa J, Kuick R, Kodaira M, Lamb B, Fawcett J, Glover T, Cram S, Hanash S: Two-dimensional separation and cloning of chromosome 1 Notl-EcoRV-derived genomic fragments. Genomics 1996, 38:124-132
31. Wimmer K, Zhu XX, Lamb BJ, Kuick R, Ambros PF, Kovar H, Thoraval D, Motyka S, Alberts JR, Hanash SM: Co-amplification of a novel gene, NAG, with the N-MYC gene in neuroblastoma Oncogene 1999, 18:233-238
32. Kawai J, Suzuki H, Taga C, Hara A, Watanabe S: Correspondence of RLGS-M spot behavior with tissue expression on mouse homologue of DP1/TB2 gene. Biochem Biophys Res Commun 1995, 213: 967-974
33. Akama TO, Okazaki Y, Ito M, Okuizumi H, Konno H, Muramatsu M, Plass C, Held WA, Hayashizaki Y: Restriction landmark genomic scanning (RLGS-M)-based genome-wide scanning of mouse liver tumors for alterations in DNA methylation status. Cancer Res 1997, 57:3294-3299
34. Zardo G, Tiirikainen MI, Hong C, Misra A, Feuerstein BG, Volik S, Collins CC, Lamborn KR, Bollen A, Pinkel D, Albertson DG, Costello JF: Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors. Nat Genet 2002, 32:453-458
35. Wimmer K, Zhu XX, Rouillard JM, Ambros PF, Lamb BJ, Kuick R, Eckart M, Weinhausl A, Fonatsch C, Hanash SM: Combined restriction landmark genomic scanning and virtual genome scans identify a novel human homeobox gene, ALX3, that is hypermethylated in neuroblastoma. Genes 2002, 33:285-294
36. Lindsay S, Bird AP: Use of restriction enzymes to detect potential gene sequences in mammalian DNA. Nature 1987, 327:336-338
37. Rouillard JM, Erson AE, Kuick R, Asakawa J, Wimmer K, Muleris M, Petty EM, Hanash S: Virtual genome scan: a tool for restriction landmark-based scanning of the human genome. Genome Res 2001, 11:1453-1459
38. Yoshikawa H, de la Monte S, Nagai H, Wands JR, Matsubara K, Fujiyama A: Chromosomal assignment of human genomic Notl restriction fragments in a two-dimensional electrophoresis profile. Genomics 1996, 31:28-35
39. Kuick R, Asakawa J, Neel JV, Satoh C, Hanash SM: High yield of restriction fragment length polymorphisms in two-dimensional separations of human genomic DNA. Genomics 1995, 25:345-353
40. Schwartz DR, Kardia SL, Shedden KA, Kuick R, Michailidis G, Taylor JM, Misek DE, Wu R, Zhai Y, Darrah DM, Reed H, Ellenson LH, Giordano TJ, Fearon ER, Hanash SM, Cho KR: Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas. Cancer Res 2002, 62:4722-4729
41. Kuick R, Asakawa J, Neel JV, Kodaira M, Satoh C, Thoraval D, Gonzalez IL, Hanash SM: Studies of the inheritance of human ribosomal DNA variants detected in two-dimensional separations of genomic restriction fragments. Genetics 1996, 144:307-316
42. Lin L, Aggarwal S, Glover TW, Orringer MB, Hanash S, Beer DG: A minimal critical region of the 8p22-23 amplicon in esophageal adenocarcinomas defined using sequence tagged site-amplification mapping and quantitative polymerase chain reaction includes the GATA-4 gene. Cancer Res 2000, 60:1341-1347
43. Huang NF, Gupta M, Varghese S, Rao S, Luke S: Detection of numerical chromosomal abnormalities in epithelial ovarian neoplasms by fluorescence in situ hybridization (FISH) and a review of the current literature. Appl Immunohistochem Mol Morphol 2002, 10: 187-193
44. Kalir T, Eisberg A, Dottino P, Cohen C: Interphase fluorescence in situ hybridization studies of ovarian adenocarcinomas using the midisatellite probe. Gynecol Oncol 1999, 72:208-214
45. Thompson FH, Taetle R, Trent JM, Liu Y, Massey-Brown K, Scott KM, Weinstein RS, Emerson JC, Alberts DS, Nelson MA: Band 1p36 abnormalities and t(1,17) in ovarian carcinoma. Cancer Genet Cytogenet 1997, 96:106-110
46. Evans MF, McDicken IW, Herrington CS: Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumours. J Pathol 1999, 189: 53-59
47. Ioakim-Liossi A, Gagos S, Athanassiades P, Athanassiadou P, Gogas J, Davaris P, Markopoulos C: Changes of chromosomes 1, 3, 6, and 11 in metastatic effusions arising from breast and ovarian cancer. Cancer Genet Cytogenet 1999, 110:34-40
48. Grandori C, Cowley SM, James LP, Eisenman RN: The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 2000, 16:653-699
49. Ingvarsson S, Sundaresan S, Jin P, Francke U, Asker C, Sumegi J, Klein G, Sejersen T: Chromosome localization and expression pattern of Lmyc and Bmyc in murine embryonal carcinoma cells. Oncogene 1988, 3:679-685
50. Schreiber-Agus N, Torres R, Horner J, Lau A, Jamrich M, DePinho RA: Comparative analysis of the expression and oncogenic activities of Xenopus c-, N-, and L-myc homologs. Mol Cell Biol 1993, 13: 2456-2468
51. Morgenbesser SD, Schreiber-Agus N, Bidder M, Mahon KA, Overbeek PA, Horner J, DePinho RA: Contrasting roles for c-Myc and L-Myc in the regulation of cellular growth and differentiation in vivo. EMBO J 1995, 14:743-756
52. Blackwell TK, Kretzner L, Blackwood EM, Eisenman RN, Weintraub H: Sequence-specific DNA binding by the c-Myc protein. Science 1990, 250:1149-1151
53. Ma A, Moroy T, Collum R, Weintraub H, Alt FW, Blackwell TK: DNA binding by N- and L-Myc proteins. Oncogene 1993, 8:1093-1098
54. DePinho RA, Hatton KS, Tesfaye A, Yancopoulos GD, Alt FW: The human MYC gene family: structure and activity of L-MYC and an L-MYC pseudogene. Genes Dev 1987, 1:1311-1326
55. Birrer MJ, Segal S, DeGreve JS, Kaye F, Sausville EA, Minna JD: L-myc cooperates with ras to transform primary rat embryo fibroblasts. Mol Cell Biol 1988, 8:2668-2673
56. Nau MM, Brooks BJ, Battey J, Sausville E, Gazdar AF, Kirsch IR, McBride OW, Bertness V, Hollis GF, Minna JD: L-MYC, a new MYC-related gene amplified and expressed in human small cell lung cancer Nature 1985, 318:69-73
57. Makela TP, Saksela K, Alitalo K: Amplification and rearrangement of L-myc in human small-cell lung cancer. Mutat Res 1992, 276:307-315
58. Nesbit CE, Tersak JM, Prochownik EV: MYC oncogenes and human neoplastic disease. Oncogene 1999, 18:3004-3016
59. Kim JO, Nau MM, Allikian KA, Makela TP, Alitalo K, Johnson BE, Kelley MJ: Co-amplification of a novel cyclophilin-like gene (PPIE) with L-myc in small cell lung cancer cell lines. Oncogene 1998, 17:1019-1026